Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Public Health Impact of Using Biosimilars, Is Automated Follow up Relevant?
Perpoil A, Grimandi G, Birklé S, Simonet JF, Chiffoleau A, Bocquet F. Perpoil A, et al. Among authors: bocquet f. Int J Environ Res Public Health. 2020 Dec 29;18(1):186. doi: 10.3390/ijerph18010186. Int J Environ Res Public Health. 2020. PMID: 33383867 Free PMC article. Review.
Biosimilars in an era of rising oncology treatment options.
Peeters M, Planchard D, Pegram M, Gonçalves J, Bocquet F, Jang H. Peeters M, et al. Among authors: bocquet f. Future Oncol. 2021 Oct;17(29):3881-3892. doi: 10.2217/fon-2021-0546. Epub 2021 Jun 30. Future Oncol. 2021. PMID: 34189937 Free article. Review.
A long war begins: biosimilars versus patented biologics.
Bocquet F, Paubel P. Bocquet F, et al. J Med Econ. 2015;18(12):1071-3. doi: 10.3111/13696998.2015.1075996. Epub 2015 Aug 27. J Med Econ. 2015. PMID: 26212478 Free article. No abstract available.
Preconceived notions about biosimilars-a French experience.
Cohen JD, Tropé S, Paubel P, Munos A, Bocquet F. Cohen JD, et al. Among authors: bocquet f. Clin Rheumatol. 2020 Aug;39(8):2251-2254. doi: 10.1007/s10067-020-05229-7. Epub 2020 Jun 22. Clin Rheumatol. 2020. PMID: 32572806
Biosimilars: complements and comments on the recent statement of the SFR and CRI. Comment on: "Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)." Schaeverbeke et al. Joint Bone Spine 2018;95:399-402.
Cohen JD, Tropé S, Munos A, Bocquet F. Cohen JD, et al. Among authors: bocquet f. Joint Bone Spine. 2019 Mar;86(2):287-288. doi: 10.1016/j.jbspin.2018.10.009. Epub 2018 Oct 27. Joint Bone Spine. 2019. PMID: 30394338 No abstract available.
61 results